UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Passive investing can simplify retirement saving by lowering costs and smoothing returns. Learn why this approach often suits long-term goals vs active strategies.
23,287 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Target delivered a solid beat-and-raise quarter, yet shares slid, illustrating a sell-the-news dynamic. With Walmart ...
FuelCell Energy leads a hydrogen stock rebound with a 15% jump as investors chase AI data center exposure. Bloom Ener...
In 2025, mackenzie scott gave away more than $7 billion to hundreds of groups through Yield Giving, but her low-profi...
Showings unveils a no-listing-fee brokerage model that relies on assisting agents and AI to speed listings, betting b...
A fresh briefing from the Joint Economic Committee shows Medicare Advantage overpayments totaling about $7 billion pe...
When rates trend downward, cash-flow investors face a tougher math as prices rise and competition heats up. This guid...
Yields on the 10-year Treasury push toward a key 4.75% level as investors weigh dividend-growth strategies against hi...
Oklo edges toward its first commercial nuclear power with government negotiations and a European funding alliance, ex...
A rising tech stock delivered a meteoric run in 2026, turning modest bets into life-changing gains as AI and data-cen...
Raising pay is not a cure for financial anxiety. New data show savings rates slipping even as wages rise, underscorin...
DTCC unveils plans to connect its tokenized securities platform to the Stellar blockchain by mid-2027, signaling a ma...